These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6248965)

  • 1. [Study of the fibrin degradation products in the synovial fluid of rheumatological diseases (author's transl)].
    Kolodie L; Phelipp X; Baccard C
    Sem Hop; 1980 May 8-15; 56(17-18):832-6. PubMed ID: 6248965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrinogen and its degradation products in the synovial fluid of 100 rheumatic patients and its comparison with the proteinogram and immunodiffusion].
    Menchón Galiana M; Serra Mercader JM; López Dasi JL; Barceló P; Fargas R
    Rev Esp Reum Enferm Osteoartic; 1975; 18(1):30-80. PubMed ID: 806107
    [No Abstract]   [Full Text] [Related]  

  • 3. Properties of fibrinogen-antigenic material on the rheumatoid synovial membrane and in the rheumatoid synovial fluid.
    Clemmensen I; Andersen RB
    J Lab Clin Med; 1978 Nov; 92(5):678-89. PubMed ID: 712203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen/fibrin degradation products in exudates from bullous dematoses.
    Mortensen T; Clemmensen I; Søndergaard J
    Acta Derm Venereol; 1979; 59(4):293-6. PubMed ID: 92141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of serum and synovial fluid fibrin degradation products (FDP) estimation in rheumatoid arthritis.
    Gulati PD; Sood KC; Saha K; Kumar A; Zizvi SN
    J Assoc Physicians India; 1982 Nov; 29(11):903-6. PubMed ID: 7130107
    [No Abstract]   [Full Text] [Related]  

  • 7. [Degradation products of fibrinogen in synovial fluid].
    Punzi L; Bertaglia E; Pengo V; Fiocco U; Todesco S
    Boll Soc Ital Biol Sper; 1979 Aug; 55(16):1576-80. PubMed ID: 553542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen-fibrin breakdown products in pathologic synovial fluids. An immunologic study.
    Gormsen J; Andersen RB; Feddersen C
    Arthritis Rheum; 1971; 14(4):503-12. PubMed ID: 4254709
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrin and fibrinogen degradation products in head- and neck-tumors (author's transl)].
    Wilmes EH; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1978 Dec; 57(12):1083-6. PubMed ID: 732487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methods of determination of fibrin fibrinogen degradation products (review of the literature)].
    Guseínov ChS; Prozorovskaia NN; Mikhaĭlova ND; Gorelova AM; Lagutina NIa
    Lab Delo; 1978; (5):259-66. PubMed ID: 79007
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological assay and radioimmunoassay of FDP on human serum (author's transl)].
    Abe K
    Rinsho Byori; 1978; 26(4):313-21. PubMed ID: 671777
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients with meningococcal infections (author's transl)].
    Bajo R; Vaca R; Elduayen R; Zarallo L; Cardesa JJ; Pérez-Miranda M
    Med Clin (Barc); 1980 Nov; 75(8):338-41. PubMed ID: 7442335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum.
    Chi DS; Chen JP
    Thromb Haemost; 1976 Apr; 35(2):423-36. PubMed ID: 823661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of fibrin-fibrinogen degradation products in the serum of newborn infants using a standardized hemagglutination inhibition test (the FDP kit)].
    Weitzel KH; Eschenbach C
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):23-8. PubMed ID: 6700599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative determination of D and E fibrinogen fragments using electroimmunodiffusion].
    Ferrari G; Fabucci C
    Boll Ist Sieroter Milan; 1976 Jul; 55(3):221-4. PubMed ID: 828057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
    Matsuda M; Baba M; Morimoto K; Nakamikawa C
    J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of fibrinogen or fibrin degradation products in the ascitic fluid].
    Kolodie L; Detante J; Rachail M
    Nouv Presse Med; 1978 Feb; 7(8):665. PubMed ID: 417295
    [No Abstract]   [Full Text] [Related]  

  • 19. [The detection of serum and urine fibrin and fibrinogen degradation products by hemagglutination inhibition test (author's transl)].
    Wang Z
    Zhonghua Nei Ke Za Zhi; 1979; 18(5):330-3. PubMed ID: 555935
    [No Abstract]   [Full Text] [Related]  

  • 20. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W; Emeis JJ; Vermond A
    Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.